Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial.
- DOI
- 10.1038/s41591-026-04762-3
- Published
- 2026 Nov 8
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-026-04762-3,
title = {Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial.},
author = {Borlaug BA and Jensen MD and Packer M and Reddy YNV and Harada T and Ghanbari F and Johnson PW and Carter RE},
year = {2026},
journal = {Nature medicine},
doi = {10.1038/s41591-026-04762-3},
url = {https://doi.org/10.1038/s41591-026-04762-3}
}RIS
TY - JOUR TI - Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial. AU - Borlaug BA AU - Jensen MD AU - Packer M AU - Reddy YNV AU - Harada T AU - Ghanbari F AU - Johnson PW AU - Carter RE PY - 2026 JO - Nature medicine DO - 10.1038/s41591-026-04762-3 UR - https://doi.org/10.1038/s41591-026-04762-3 ER -
APA
BA, B., MD, J., M, P., YNV, R., T, H., F, G., PW, J., & RE, C. (2026). Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial.. Nature medicine. https://doi.org/10.1038/s41591-026-04762-3
Source records
- pubmed · retrieved 2026-11-10T12:02:14.148Z